← Back to headlines
Merck Reports Quarterly Loss Despite Sales Increase
Merck posted a quarterly loss primarily due to a charge related to Cidara, even as its sales rose by 5%.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
